Multifunctional Microporous MOFs Exhibiting Gas/Hydrocarbon Adsorption Selectivity, Separation Capability and Three‐Dimensional Magnetic Ordering K Li, DH Olson, JY Lee, W Bi, K Wu, T Yuen, Q Xu, J Li Advanced Functional Materials 18 (15), 2205-2214, 2008 | 171 | 2008 |
Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent KE Wu, J Li, W Wang, DA Winstead Journal of pharmaceutical sciences 98 (7), 2422-2431, 2009 | 165 | 2009 |
Crystalline mesophases: structure, mobility, and pharmaceutical properties E Shalaev, K Wu, S Shamblin, JF Krzyzaniak, M Descamps Advanced drug delivery reviews 100, 194-211, 2016 | 55 | 2016 |
Precipitation of a biodegradable polymer using compressed carbon dioxide as antisolvent K Wu, J Li The Journal of Supercritical Fluids 46 (2), 211-216, 2008 | 37 | 2008 |
Freezing of aqueous solutions and chemical stability of amorphous pharmaceuticals: water clusters hypothesis E Shalaev, A Soper, JA Zeitler, S Ohtake, CJ Roberts, MJ Pikal, K Wu, ... Journal of Pharmaceutical Sciences 108 (1), 36-49, 2019 | 26 | 2019 |
Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof AV Gore, K Karami, K Wu, RS Graham, SW Smith US Patent 8,772,245, 2014 | 15 | 2014 |
A new hydrate of cyclosporine: structural and physicochemical characterization K Wu, A Gore, R Graham Journal of Pharmaceutical Sciences 107 (12), 3070-3079, 2018 | 9 | 2018 |
Water structure in glycerol: Spectroscopic and computer simulation investigation of hydrogen bonding and water clustering K Wu, S Feng, A Hedoux, E Shalaev Journal of Molecular Liquids 355, 118916, 2022 | 8 | 2022 |
Suspension compositions of cyclosporin A for subconjunctival and periocular injection AV Gore, H Hou, CP Pujara, S Neervannan, K Wu US Patent 10,780,048, 2020 | 8 | 2020 |
Quality assessment of API in semisolid topical drug products K Wu, T Yeoh, YL Hsieh, DW Osborne The Role of Microstructure in Topical Drug Product Development, 109-154, 2019 | 8 | 2019 |
7-[3, 5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof GF Ambrus, K Karami, K Wu US Patent 8,629,185, 2014 | 8 | 2014 |
Best Practices and guidelines (2022) for Scale-up and Tech transfer in Freeze-Drying based on Case Studies. Part 1: challenges during Scale up and transfer S Tchessalov, E Shalaev, B Bhatnagar, S Nail, A Alexeenko, F Jameel, ... AAPS PharmSciTech 24 (1), 11, 2022 | 7 | 2022 |
Prostamide-containing intraocular implant PM Hughes, J Shen, MR Robinson, DF Woodward, RM Burk, H Liu, ... US Patent 9,289,413, 2016 | 7 | 2016 |
Cyclosporin A form 2 and method of making same K Wu, SW Smith US Patent 8,796,221, 2014 | 4 | 2014 |
Prostamide-containing intraocular implant PM Hughes, J Shen, MR Robinson, DF Woodward, RM Burk, H Liu, ... US Patent 9,889,142, 2018 | 3 | 2018 |
Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof K Wu, GF Ambrus US Patent 9,353,079, 2016 | 3 | 2016 |
Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof K Wu, S Feng, TK Karami, SW Smith US Patent 9,120,738, 2015 | 3 | 2015 |
Best practices and guidelines (2022) for scale-up and technology transfer in freeze drying based on case studies. Part 2: past practices, current best practices, and … S Tchessalov, E Shalaev, B Bhatnagar, S Nail, A Alexeenko, F Jameel, ... AAPS PharmSciTech 24 (4), 96, 2023 | 2 | 2023 |
Solubilization of Cyclosporine in Topical Ophthalmic Formulations: Preformulation Risk Assessment on a New Solid Form K Wu, A Gore, R Graham, R Meller Journal of Pharmaceutical Sciences 108 (10), 3233-3239, 2019 | 2 | 2019 |
7-[3, 5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof GF Ambrus, TK Karami, K Wu US Patent 9,181,176, 2015 | 2 | 2015 |